Ground-breaking research elucidates a fundamental link between human zinc levels and the susceptibility to type 2 diabetes and non-alcoholic fatty liver disease.
Published in eLife, this study enhances our comprehension of zinc’s role in metabolism, offering novel insights into potential therapeutic targets for prevalent metabolic disorders.
It provides compelling genetic evidence and investigates the influential role of zinc in systemic blood glucose levels and diabetes risk.
Zinc and Metabolic Health
Zinc is pivotal for insulin production and glucose metabolism, with an increase in zinc intake linked to improved blood glucose control in prediabetes and type 2 diabetes patients.
Individuals possessing mutations in a vital zinc transporter protein exhibit a diminished risk of diabetes, underlining zinc’s significance in metabolic health.
Unraveling the Mechanism
The study led by Shek Man Chim, explored the protective aspect of zinc against diabetes through testing loss-of-function mutations and identified a rare mutation in the zinc transporter protein, SLC39A5, correlating with elevated circulating zinc levels and diminished diabetes risk.
Insightful Genetic Analysis
Utilizing advanced genetic analysis from participants of the Regeneron Genetics Center-Geisinger Health System DiscovEHR study, the research identified the crucial link, SLC39A5, between zinc and diabetes.
Mutations in SLC39A5 resulting in elevated zinc levels were confirmed to be associated with a decreased risk of type 2 diabetes through extensive meta-analysis involving multiple studies and diverse participants.
The Role of SLC39A5 in Mice
Further, mice engineered to lack the SLC39A5 transporter exhibited elevated zinc levels and when subjected to high-fat, high-fructose diets, showed significant reductions in fasting glucose, decreased insulin resistance, and less accumulation of fat in the liver compared to controls, affirming the protective role of zinc in metabolic disorders.
Exploring Therapeutic Potential
The elucidation of the protective mechanism of zinc against high blood sugar levels and fatty liver disease sets the stage for exploring the blocking of SLC39A5 as a potential therapeutic strategy, especially in conditions where zinc supplementation alone is not sufficient.
This approach might offer a novel pathway to mitigate the impacts of type 2 diabetes and related metabolic disorders.
Addressing Gender Differences and Further Exploration
The study indicated some differences in the metabolic consequences of SLC39A5 inactivation between male and female mice, necessitating further research to fully understand these distinctions, along with a more detailed exploration of SLC39A5’s role in pancreatic cell function and glucose tolerance.
Conclusion
This innovative study paves the way for a deeper understanding of zinc’s protective role in metabolic health, particularly in type 2 diabetes and fatty liver disease.
By uncovering the mechanistic link through advanced genetic analysis and lab studies, it opens up the possibility of new therapeutic interventions, potentially transforming the treatment landscape for these widespread metabolic conditions.
The highlighted potential of targeting the zinc transporter protein, SLC39A5, could offer a novel approach to managing and possibly preventing the progression of metabolic diseases where current interventions and zinc supplementation are not adequate.
The observations from this study accentuate the imperative for further research to fully comprehend the implications and to refine the approaches for leveraging zinc’s protective mechanisms in metabolic health.
If you care about diabetes, please read studies that pomace olive oil could help lower blood cholesterol, and honey could help control blood sugar.
For more information about diabetes, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes and results showing plant-based protein foods may help reverse type 2 diabetes.
The research findings can be found in eLife.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
